[Pre-therapeutic and evolutive characteristics of patients suffering from chronic myeloid leukemia, in Abidjan, Ivory Coast].

CONCLUSION: The presence of an additional anomaly constitutes a pejorative element refractory to imatinib.
PMID: 31088680 [PubMed - as supplied by publisher]

Source: Bulletin du Cancer - May 10, 2019 Category: Cancer & Oncology Authors: Silué DA, Kouakou B, Nanho CD, Kamara I, Djoko S, Sowhe T, Meité N, Ayemou R, Emeuraude N, Tolo A, Koffi G, Sanogo I Tags: Bull Cancer Source Type: research